Cover Image
市場調查報告書

全球醫療用大麻市場 2017-2027年:慢性疼痛·關節炎·偏頭痛·癌症

Global Medical Marijuana Market 2017-2027: Chronic Pain, Arthritis, Migraine, Cancer, National Markets, Patent Analysis, Leading Companies

出版商 Visiongain Ltd 商品編碼 562113
出版日期 內容資訊 英文 120 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
全球醫療用大麻市場 2017-2027年:慢性疼痛·關節炎·偏頭痛·癌症 Global Medical Marijuana Market 2017-2027: Chronic Pain, Arthritis, Migraine, Cancer, National Markets, Patent Analysis, Leading Companies
出版日期: 2017年08月22日 內容資訊: 英文 120 Pages
簡介

全球醫療用大麻的市場規模在2016年為120億美金,預計在預測期間前半部將以18%的年複合成長率 (CAGR) 成長。

本報告提供全球醫療用大麻市場相關調查分析,提供市場概要,各應用·地區的市場預測,主要地區市場分析,市場影響要素分析,並提供主要企業簡介等資訊。

第1章 調查概要

第2章 醫療用大麻市場簡介

第3章 全球醫療用大麻市場預測

  • 市場分析:各應用領域
  • 市場分析:各地區

第4章 全球醫療用大麻市場預測:各應用領域

  • 概要
  • 慢性疼痛
  • 關節炎
  • 偏頭痛
  • 癌症
  • 其他

第5章 主要國家市場

  • 全球醫療用大麻市場:地區分析
  • 概要
    • 北美
    • 歐洲
    • 其他 (RoW)

第6章 全球醫療用大麻市場:定性分析

  • 波特的五力分析
  • 促進要素·抑制因素
  • 專利分析

第7章 醫療用大麻市場上主要企業

  • Cara Therapeutics, Inc.
  • Cannabis Sativa, Inc.
  • CannaGrow Holdings Inc.
  • Aphios Corporation
  • United Cannabis Corporation
  • Growblox Sciences, Inc.
  • GreenGro Technologies, Inc.
  • GW Pharmaceuticals, PLC.
  • International Consolidated Companies, Inc.
  • Lexaria Bioscience Corp.
  • 醫療用大麻製造的參與企業

第8章 結論

  • 目前主要市場區隔
  • 主要地區市場
  • 新興市場
  • 市場未來如何?

附錄

圖表清單

目錄
Product Code: PHA0228

The global medical marijuana market was valued at $12bn in 2016 and is projected to grow at a CAGR of 18% in the first half of the forecast period. The market is dominated by the Chronic Pain submarket which held 40% share of that market in 2016.

How this report will benefit you

Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 120-page report you will receive 87 charts - all unavailable elsewhere.

The 120-page report provides clear detailed insight into the global medical marijuana market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Report Scope

  • Global Medical Marijuana Market forecasts from 2017-2027
  • Revenue forecast for the medical marijuana market by Application:
  • Chronic Pain
  • Arthritis
  • Migraine
  • Cancer
  • Others

Each submarket is further divided by region: North America, Europe, RoW

  • This report provides individual revenue forecasts to 2027 for these regional and national medical marijuana markets:
  • North America:
  • USA
  • Canada
  • Europe:
  • Belgium
  • Croatia
  • Finland
  • France
  • Italy
  • Rest of Europe
  • RoW:
  • Israel
  • Australia
  • Other Countries

image1

  • This report discusses the leading companies in the global medical marijuana market:
  • Cara Therapeutics, Inc.
  • Cannabis Sativa, Inc.
  • CannaGrow Holdings, Inc.
  • Aphios Corporation
  • United Cannabis Corporation
  • Growblox Sciences, Inc.
  • GreenGro Technologies, Inc.
  • GW Pharmaceutical, PLC.
  • International Consolidated Companies, Inc.
  • Lexaria Biosciences Corp.
  • This report also listed 84 other companies involved in medical marijuana production, including their reported revenues (when available) and number of employees
  • This report provides a patent analysis table for medical marijuana
  • This report discusses the drivers, restraints as well as porter's five forces analysis of the global medical marijuana market

Visiongain's study is intended for anyone requiring commercial analyses for the global medical marijuana market. You find data, trends and predictions.

Table of Contents

1. Report Overview

  • 1.1 Global Medical Marijuana Market Overview
  • 1.2 Research Methodology
    • 1.2.1 Primary Research
    • 1.2.2 Secondary Research
  • 1.3 Market Evaluation & Forecasting Methodology
  • 1.4 Global Medical Marijuana Market Segmentation
  • 1.5 Overview of Findings
  • 1.6 Why You Should Read This Report
  • 1.7 How This Report Delivers?
  • 1.8 Key Questions Answered by This Analytical Report
  • 1.9 Frequently Asked Questions (FAQ)
  • 1.10 Who is This Report For?
  • 1.11 Associated Visiongain Reports
  • 1.12 About Visiongain

2. Introduction to Medical Marijuana Market

3. Global Medical Marijuana Market Forecast 2017-2027

  • 3.1 Market Breakdown by Application, 2017-2027
  • 3.2 Market Breakdown by Geography, 2017-2027

4. Global Medical Marijuana Market by Application: Market Forecast 2017-2027

  • 4.1 Overview
  • 4.2 Chronic Pain
  • 4.3 Arthritis
  • 4.4 Migraine
  • 4.5 Cancer
  • 4.6 Others

5. Leading National Market, 2017-2027

  • 5.1 Geographical Breakdown of the Global Medical Marijuana Market
  • 5.2 Overview
    • 5.2.1 North America Medical Marijuana Market Forecast, 2017-2027
      • 5.2.1.1 USA Medical Marijuana Market Forecast, 2017-2027
      • 5.2.1.2 Canada Medical Marijuana Market Forecast, 2017-2027
    • 5.2.2 European Medical Marijuana Market Forecast, 2017-2027
      • 5.2.2.1 Belgium Medical Marijuana Market Forecast, 2017-2027
      • 5.2.2.2 Croatia Medical Marijuana Market Forecast, 2017-2027
      • 5.2.2.3 Finland Medical Marijuana Market Forecast, 2017-2027
      • 5.2.2.4 France Medical Marijuana Market Forecast, 2017-2027
      • 5.2.2.5 Italy Medical Marijuana Market Forecast, 2017-2027
      • 5.2.2.6 Rest of Europe Marijuana Market Forecast, 2017-2027
    • 5.2.3 RoW Medical Marijuana Market Forecast, 2017-2027
      • 5.2.3.1 Israel Medical Marijuana Market Forecast, 2017-2027
      • 5.2.3.2 Australia Medical Marijuana Market Forecast, 2017-2027
      • 5.2.3.3 Other Countries Marijuana Market Forecast, 2017-2027

6. Global Medical Marijuana Market, Qualitative Analysis, 2017-2027

  • 6.1 Porter's Five Forces Analysis of the Medical Marijuana Market 2017-2027
    • 6.1.1 Bargaining Power of Buyers (Low)
    • 6.1.2 Bargaining Power of Suppliers (High)
    • 6.1.3 Threat of New Entrants (Low)
    • 6.1.4 Threat of Substitute Products (High)
    • 6.1.5 Intensity of Competitive Rivalry (High)
  • 6.2 Drivers & Restraints
    • 6.2.1 Increasing Prevalence of Cancer
    • 6.2.2 Increasing Research in Medical Marijuana
    • 6.2.3 Growing Number of Mergers and Acquisitions
    • 6.2.4 Increasing Funding for Cancer Research by Governmental Organisations
    • 6.2.5 Increasing Investment from Government, Public and Private Sector
    • 6.2.6 Increased Focus towards Advanced Treatment Protocols
    • 6.2.7 Increased Awareness to Reduce Healthcare Costs
    • 6.2.8 Opportunities in Emerging Economies
  • 6.3 Patent Analysis

7. Leading Companies in Medical Marijuana Market

  • 7.1 Cara Therapeutics, Inc.
    • 7.1.1 Cara Therapeutics, Inc.: Company Overview
    • 7.1.2 Cara Therapeutics, Inc.: Product Portfolio
  • 7.2 Cannabis Sativa, Inc.
    • 7.2.1 Cannabis Sativa, Inc.: Company Overview
    • 7.2.2 Cannabis Sativa, Inc.: Recent Developments
  • 7.3 CannaGrow Holdings Inc.
    • 7.3.1 CannaGrow Holdings Inc.: Company Overview
  • 7.4 Aphios Corporation
    • 7.4.1 Aphios Corporation: Company Overview
    • 7.4.2 Aphios Corporation: Product Portfolio
    • 7.4.3 Aphios Corporation: Recent Developments
  • 7.5 United Cannabis Corporation
    • 7.5.1 United Cannabis Corporation: Company Overview
    • 7.5.2 United Cannabis Corporation: Recent Developments
  • 7.6 Growblox Sciences, Inc.
    • 7.6.1 Growblox Sciences, Inc.: Company Overview
    • 7.6.2 Growblox Sciences, Inc.: Recent Developments
  • 7.7 GreenGro Technologies, Inc.
    • 7.7.1 GreenGro Technologies, Inc.: Company Overview
    • 7.7.2 GreenGro Technologies, Inc.: Product Portfolio
    • 7.7.3 GreenGro Technologies, Inc.: Recent Developments
  • 7.8 GW Pharmaceuticals, PLC.
    • 7.8.1 GW Pharmaceuticals, PLC.: Company Overview
    • 7.8.2 GW Pharmaceuticals, PLC.: Product Portfolio
    • 7.8.3 GW Pharmaceuticals, PLC.: Recent Developments
  • 7.9 International Consolidated Companies, Inc.
    • 7.9.1 International Consolidated Companies, Inc.: Company Overview
  • 7.10 Lexaria Bioscience Corp.
    • 7.10.1 Lexaria Bioscience Corp.: Company Overview
  • 7.11 Companies involved in Medical Marijuana Production

8. Conclusions

  • 8.1 Current Leading Segments
  • 8.2 Leading Regional Markets
  • 8.3 Emerging Markets
  • 8.4 The Future of the Market?

Appendices

  • Associated Visiongain Reports
  • Visiongain Report Sales Order Form
  • About Visiongain
  • Visiongain report evaluation form

List of Tables

  • Table 3.1. Global Medical Marijuana Market Forecast ($bn, AGR%, CAGR%) 2017-2027
  • Table 4.1. Global Medical Marijuana Market Forecast, by Application ($bn, AGR%, CAGR%) 2017-2027
  • Table 4.2. Global Medical Marijuana Market For Chronic Pain ,Forecast, ($bn, AGR%, CAGR%) 2017-2027
  • Table 4.3. Global Chronic Pain for Medical Marijuana Market Forecast, by Geography, ($bn, AGR%, CAGR%) 2017-2027
  • Table 4.4. Global Arthritis for Medical Marijuana Market Forecast, ($bn, AGR%, CAGR%) 2017-2027
  • Table 4.5. Global Medical Marijuana Market For Arthritis, Forecast, by Geography ($bn, AGR%, CAGR%) 2017-2027
  • Table 4.6. Global Medical Marijuana Market For Migraine Forecast, ($bn, AGR%, CAGR%) 2017-2027
  • Table 4.7. Global Medical Marijuana Market For Migraine Forecast, by Geography ($bn, AGR%, CAGR%) 2017-2027
  • Table 4.8. Global Medical Marijuana Market For Cancer Forecast, by Geography ($bn, AGR%, CAGR%) 2017-2027
  • Table 4.9. Global Medical Marijuana Market For Cancer Forecast, by Geography ($bn, AGR%, CAGR%) 2017-2027
  • Table 4.10. Global Medical Marijuana Market For Other Forecast ($bn, AGR%, CAGR%) 2017-2027
  • Table 4.11. Global Other Medical Marijuana Market Forecast, by Geography ($bn, AGR%, CAGR%) 2017-2027
  • Table 5.1. Global Medical Marijuana Market Forecast, by Geography ($bn, AGR%, CAGR%) 2017-2027
  • Table 5.2. North America Medical Marijuana Market Forecast, by Country ($bn, AGR%, CAGR%) 2017-2027
  • Table 5.3. USA Medical Marijuana Market Forecast, ($bn, AGR%, CAGR%) 2017-2027
  • Table 5.4. Canada Medical Marijuana Market Forecast, ($bn, AGR%, CAGR%) 2017-2027
  • Table 5.5. European Medical Marijuana Market Forecast, by Country ($bn, AGR%, CAGR%) 2017-2027
  • Table 5.6. Belgium Medical Marijuana Market Forecast, ($bn, AGR%, CAGR%) 2017-2027
  • Table 5.7. Croatia Medical Marijuana Market Forecast, ($bn, AGR%, CAGR%) 2017-2027
  • Table 5.8. Finland Medical Marijuana Market Forecast, ($bn, AGR%, CAGR%) 2017-2027
  • Table 5.9. France Medical Marijuana Market Forecast, ($bn, AGR%, CAGR%) 2017-2027
  • Table 5.10. Italy Medical Marijuana Market Forecast, ($bn, AGR%, CAGR%) 2017-2027
  • Table 5.11. Rest of Europe Medical Marijuana Market Forecast, ($bn, AGR%, CAGR%) 2017-2027
  • Table 5.12. Rest of World Medical Marijuana Market Forecast, by Country ($bn, AGR%, CAGR%) 2017-2027
  • Table 5.13. Israel Medical Marijuana Market Forecast, ($bn, AGR%, CAGR%) 2017-2027
  • Table 5.14. Australia Medical Marijuana Market Forecast, ($bn, AGR%, CAGR%) 2017-2027
  • Table 5.15. Other Countries Medical Marijuana Market Forecast, ($bn, AGR%, CAGR%) 2017-2027
  • Table 6.1. Worldwide Estimated Incidence and Prevalence of all Cancer Types, (2012)
  • Table 6.2. Patent Analysis for Medical Marijuana
  • Table 7.1. Cara Therapeutics, Inc.: Company Overview
  • Table 7.2. Cara Therapeutics, Inc.: Product Portfolio
  • Table 7.3. Cannabis Sativa, Inc.: Company Overview
  • Table 7.4. Cannabis Sativa, Inc.: Recent Developments
  • Table 7.5. CannaGrow Holdings Inc.: Company Overview
  • Table 7.6. Aphios Corporation: Company Overview
  • Table 7.7. Aphios Corporation: Product Portfolio
  • Table 7.8. Aphios Corporation.: Recent Developments
  • Table 7.9. United Cannabis Corporation: Company Overview
  • Table 7.10. United Cannabis Corporation.: Recent Developments
  • Table 7.11. Growblox Sciences, Inc.: Company Overview
  • Table 7.12. Growblox Sciences, Inc.: Recent Developments
  • Table 7.13. GreenGro Technologies, Inc.: Company Overview
  • Table 7.14. GreenGro Technologies, Inc.: Product Portfolio
  • Table 7.15. GreenGro Technologies, Inc.: Recent Developments
  • Table 7.16. GW Pharmaceuticals, PLC.: Company Overview
  • Table 7.17. GW Pharmaceuticals, PLC.: Product Portfolio
  • Table 7.18. GW Pharmaceuticals, PLC.: Recent Developments
  • Table 7.19. International Consolidated Companies, Inc.: Company Overview
  • Table 7.20. Lexaria bioscience Corp.: Company Overview
  • Table 7.21. Other Companies Involved in Medical Marijuana Production

List of Figures

  • Figure 3.1. Global Medical Marijuana Market, by Application, ($bn), 2017-2027
  • Figure 3.2. Global Medical Marijuana Market, by Geography, ($bn), 2017-2027
  • Figure 4.1. Global Medical Marijuana Market, by Application, Market Share (%), 2016
  • Figure 4.2. Global Medical Marijuana Market, by Application, Forecast ($bn) 2017-2027
  • Figure 4.3. Global Chronic Pain for Medical Marijuana Market Forecast, by Geography, ($bn) 2017-2027
  • Figure 4.4. Global Medical Marijuana Market for Arthritis Forecast, by Geography, ($bn) 2017-2027
  • Figure 4.5. Global Medical Marijuana Market for Migraine Forecast, by Geography, ($bn) 2017-2027
  • Figure 4.6. Global Medical Marijuana Market for Cancer Forecast, by Geography, ($bn) 2017-2027
  • Figure 4.7. Global Other Medical Marijuana Market Forecast, by Geography, ($bn) 2017-2027
  • Figure 5.1. Global Medical Marijuana Market Forecast, by Geography ($bn) 2017-2027
  • Figure 5.2. Global Medical Marijuana Market Forecast, by Geography, Market Share (%), 2016
  • Figure 5.3. North America Medical Marijuana Market Forecast, by Country ($bn) 2017-2027
  • Figure 5.4. North America Medical Marijuana Market, by Country, Market Share (%), 2017
  • Figure 5.5. USA Medical Marijuana Market Forecast ($bn) 2017-2027
  • Figure 5.6. Medical Marijuana Market Forecast ($bn) 2017-2027
  • Figure 5.7. Europe Medical Marijuana Market Forecast, by Country ($bn) 2017-2027
  • Figure 5.8. Europe Medical Marijuana Market, by Country, Market Share (%), 2017
  • Figure 5.9. Belgium Medical Marijuana Market Forecast ($bn) 2017-2027
  • Figure 5.10. Croatia Medical Marijuana Market Forecast ($bn) 2017-2027
  • Figure 5.11. Finland Medical Marijuana Market Forecast ($bn) 2017-2027
  • Figure 5.12. France Medical Marijuana Market Forecast ($bn) 2017-2027
  • Figure 5.13. Italy Medical Marijuana Market Forecast ($bn) 2017-2027
  • Figure 5.14. Rest of Europe Medical Marijuana Market Forecast ($bn) 2017-2027
  • Figure 5.15. Rest of World Medical Marijuana Market Forecast, by Country ($bn) 2017-2027
  • Figure 5.16. Rest of World Medical Marijuana Market, by Country, Market Share (%), 2016
  • Figure 5.17. Israel Medical Marijuana Market Forecast ($m) 2017-2027
  • Figure 5.18. Australia Medical Marijuana Market Forecast ($bn) 2017-2027
  • Figure 5.19. Other Countries Medical Marijuana Market Forecast ($bn) 2017-2027
  • Figure 6.1. Porter's Five Forces Analysis of the Medical Marijuana Market
  • Figure 7.1. Cara Therapeutics, Inc., Revenue, ($m), 2012-2016
  • Figure 7.2. Cannabis Sativa, Inc., Revenue, ($m), 2014-2016
  • Figure 7.3. GreenGro Technologies, Inc., Revenue, ($m), 2014-2015
  • Figure 7.4. GW Pharmaceuticals, PLC. Revenue, ($m), 2012-2016
  • Figure 7.5. GW Pharmaceuticals, PLC. Geographical Presence Share (%), 2016
  • Figure 7.6. Lexaria Corp., Revenue, ($m), 2012-2016
  • Figure 8.1. World Medical marijuana, by Application, ($bn), 2016-2027
  • Figure 8.2. World Medical marijuana, by Geography, ($bn), 2016-2027

Companies Listed

  • Acacia Diversified Holdings, Inc.
  • Advesa
  • Affinor Growers, Inc.
  • Agritek Holdings, Inc.
  • Aja Cannafacturing, Inc.
  • Alliance Growers Corp.
  • Alphora Research Inc.
  • Alternative Energy Partners, Inc.
  • American Green, Inc.
  • AmeriCann, Inc.
  • Anandia Laboratories Inc.
  • Aphios Corporation
  • Aurora Cannabis, Inc.
  • Avid Growing Systems Inc.
  • Azienda Sanitaria Locale
  • Bang Holdings Corp.
  • Battelle Energy Alliance, LLC
  • Bedrocan Cannabis Corp.
  • Beleave, Inc.
  • Bingo Nation, Inc.
  • Café Serendipity Holdings, Inc.
  • Canada House Wellness Group, Inc.
  • Canadian Cannabis Corp.
  • Cann Group Ltd.
  • Cannabics Pharmaceuticals, Inc.
  • Cannabis Leaf, Inc.
  • Cannabis Sativa, Inc.
  • CannaGrow Holdings, Inc.
  • CannaRoyalty Corp.
  • CannaSys, Inc.
  • CanniMed Therapeutics, Inc.
  • CannLabs, Inc.
  • Canopy Growth Corp.
  • Cara Therapeutics, Inc.
  • Chuma Holdings, Inc.
  • CorGreen Technologies Holding Corp.
  • Cronos Group, Inc.
  • Eden Holdings LLC
  • Embera Neurotherapeutics, Inc
  • Emblem Corp.
  • Emerald Health Therapeutics, Inc.
  • Endocan Corp.
  • Enertopia Corp.
  • Evergreen-Agra, Inc.
  • F Hoffmann La Roche AG
  • Ficaar, Inc.
  • Gala Global, Inc.
  • General Cannabis Corp.
  • Golden Leaf Holdings Ltd.
  • Green & Hill Industries, Inc.
  • Greener Clouds LLC
  • GreenGro Technologies, Inc.
  • Grow Condos, Inc.
  • Grow Solutions Holdings, Inc.
  • Growblox Sciences, Inc.
  • GrowLife, Inc.
  • GW Pharmaceutical, PLC.
  • Hangzhou Alltest Biotech Co., Ltd.
  • Herbal Biotech Pathways Labs
  • Hi Brands International Inc.,
  • High Hampton Holdings Corp.
  • Hythiam Inc.
  • iBudtender, Inc.
  • ICC International Cannabis Corp.
  • Incredibowl Industries, LLC
  • Innocorp, Ltd.
  • International Consolidated Companies, Inc.
  • Kaya Holdings, Inc.
  • Kona Gold Solutions, Inc.
  • Kubby Patent and Licenses, LLC
  • Kush Cups
  • Labone, Inc.
  • Lexaria Biosciences Corp.
  • Lotus Ventures, Inc.
  • Maple Leaf Green World, Inc.
  • Marapharm Ventures, Inc.
  • Marijuana Company of America, Inc.
  • MariMed, Inc.
  • Matica Enterprises, Inc.
  • MediJane Holdings, Inc.
  • MedReleaf Corp.
  • Monarch America, Inc.
  • Murty Pharmaceuticals, Inc.
  • Nass Valley Gateway Ltd.
  • Natural Rx Investment Club LLC
  • NEWCO
  • North American Cannabis Holdings, Inc.
  • Northsight Capital, Inc.
  • Notis Global, Inc.
  • Nutritional High International, Inc.
  • Occidental Development Group, Inc.
  • Omeros Corporation
  • Optileaf Inc.
  • OrganiGram Holdings, Inc.
  • PotNetwork Holdings, Inc.
  • Primco Management, Inc.
  • Puration, Inc.
  • Qingdao Aihualong Biotechnology Co., Ltd.
  • Qingdao Chenxuntong Trading Co., Ltd.
  • Qingdao Zhaxi Biological Technology Co., Ltd.
  • Rottapharm S.P.A.
  • Santo Mining Corp.
  • Shanghai Fuzhen Technology Co.,Ltd.
  • Shanghai Sun-Sail Pharmaceutical Science & Technology Co., Ltd.
  • Sixty Six Oilfield Services, Inc.
  • Supreme Pharmaceuticals, Inc.
  • Terra Tech Corp.
  • Tetra Bio-Pharma, Inc.
  • THC Therapeutics, Inc.
  • The Hydroponics Co. Ltd.
  • True Leaf Medicine International Ltd.
  • Tweed Inc.
  • Ultra Sun Corporation
  • United Cannabis Corp.
  • United Cannabis Corporation
  • Verde Science, Inc.
  • Veritas Pharma, Inc.
  • Vessel Life Sciences (VLS)
  • Vodis Pharmaceuticals, Inc.
  • Volo Trade, Inc.
  • WEED, Inc.
  • WeedMD, Inc.
  • Wild Earth Naturals, Inc.
  • Wildflower Marijuana, Inc.
  • Worldwide Marijuana, Inc.
  • Wrapmail Inc.
  • Wuhu Ufabric New Sound-Absorbing Material Co., Ltd.
  • Yingkou Xinyi Textile Co., Ltd

List of Organizations Mentioned in the Report

  • Alaska Department of Health and Social Services
  • Commonwealth Therapeutic Goods Administration
  • Dalian Polytechnic University
  • Drug Policy Alliance (DPA)
  • European Medicines Agency (EMA)
  • Food and Drug Administration (FDA)
  • Health Canada
  • National Agency of the Safety of Medicine and Health Products
  • National Cancer Research Institute
  • National Institutes of Health (NIH)
  • National Research Council of Canada
  • Shanxi University
  • Supreme Court of Canada
  • University Of Saskatchewan
  • World Health Organization
Back to Top